Fundamental Analysis of CVRX INC(NASDAQ:CVRX) stock

Fundamental Rating

CVRX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CVRX have multiple concerns. CVRX is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CVRX has reported negative net income.

CVRX had a negative operating cash flow in the past year.

In the past 5 years CVRX always reported negative net income.

In the past 5 years CVRX always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -45.80%, CVRX is not doing good in the industry: 64.71% of the companies in the same industry are doing better.

With a Return On Equity value of -89.71%, CVRX is not doing good in the industry: 64.17% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-45.8%
ROE	-89.71%
ROIC	N/A

ROA(3y)-32.39%

ROA(5y)-33.93%

ROE(3y)-40.56%

ROE(5y)-357.7%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 84.16%, CVRX belongs to the top of the industry, outperforming 95.19% of the companies in the same industry.

In the last couple of years the Gross Margin of CVRX has grown nicely.

The Profit Margin and Operating Margin are not available for CVRX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	84.16%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.34%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.

CVRX has more shares outstanding than it did 1 year ago.

The debt/assets ratio for CVRX is higher compared to a year ago.

2.2 Solvency

CVRX has an Altman-Z score of -2.43. This is a bad value and indicates that CVRX is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of CVRX (-2.43) is worse than 63.64% of its industry peers.

A Debt/Equity ratio of 0.76 indicates that CVRX is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.76, CVRX is doing worse than 73.26% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF	N/A
Altman-Z	-2.43

ROIC/WACCN/A

WACC8.91%

2.3 Liquidity

A Current Ratio of 11.32 indicates that CVRX has no problem at all paying its short term obligations.

CVRX has a better Current ratio (11.32) than 94.12% of its industry peers.

A Quick Ratio of 10.23 indicates that CVRX has no problem at all paying its short term obligations.

CVRX has a Quick ratio of 10.23. This is amongst the best in the industry. CVRX outperforms 93.58% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	11.32
Quick Ratio	10.23

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CVRX have decreased strongly by -31.71% in the last year.

The Revenue has grown by 34.36% in the past year. This is a very strong growth!

Measured over the past years, CVRX shows a very strong growth in Revenue. The Revenue has been growing by 86.58% on average per year.

EPS 1Y (TTM)-31.71%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-32.56%

Revenue 1Y (TTM)34.36%

Revenue growth 3Y86.58%

Revenue growth 5YN/A

Sales Q2Q%27.23%

3.2 Future

Based on estimates for the next years, CVRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.61% on average per year.

Based on estimates for the next years, CVRX will show a very strong growth in Revenue. The Revenue will grow by 32.16% on average per year.

EPS Next Y-35.36%

EPS Next 2Y-4.94%

EPS Next 3Y4.62%

EPS Next 5Y9.61%

Revenue Next Year29.71%

Revenue Next 2Y28.2%

Revenue Next 3Y27.46%

Revenue Next 5Y32.16%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVRX. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVRX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-4.94%

EPS Next 3Y4.62%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CVRX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CVRX INC

NASDAQ:CVRX (11/21/2024, 8:21:40 PM)

After market: 14.88 +0.11 (+0.74%)

14.77

+1.25 (+9.25%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap358.32M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-45.8%
ROE	-89.71%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	84.16%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	11.32
Quick Ratio	10.23
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-31.71%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-35.36%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)34.36%

Revenue growth 3Y86.58%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

CVRX INC (CVRX)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens